Clinical Trial Update: Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 2/3 study evaluating chemotherapy plus rituximab for aggressive mature B-cell non-Hodgkin lymphoma in chil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mature B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Children's Cancer Group, China | Conditions: Mature B-cell Non-Hodgkin Lymphoma | Phase 2, Phase 3 | Status: RECRUITING